Saturday, November 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 2, 2026

Hess Midstream (HESM) Q4 2025 Earnings Transcript

View original at finance.yahoo.com
“Net interest, excluding amortization of deferred finance costs, was approximately $54 million, resulting in adjusted free cash flow of approximately $208 million. We had a drawn balance of $338 million on o”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Adjusted free cash flow expected to reach $850-900 million in 2026, representing 12% growth over 2025

    80% confidence
  • Capital spending expected to decrease 40% in 2026 to approximately $150 million

    80% confidence
  • Conservative financial strategy is consistent with volume profile and Chevron's target of 200,000 barrels of oil per day plateau production in the Bakken

    80% confidence
  • Revenues approximately 95% protected by minimum volume commitments (MVCs) on full-year basis in 2026

    80% confidence
  • Chevron targets 200,000 barrels of oil equivalent per day plateau production in the Bakken

    80% confidence
  • 2025 delivered strong results with full-year net income of approximately $685 million and adjusted EBITDA of $1.238 billion, representing 9% growth from 2024

    80% confidence
  • Capital spending expected to decrease further to less than $75 million per year in 2027 and 2028

    80% confidence
  • In 2025, Hess Midstream continued record of strong performance execution, completing multiyear projects on time and on budget

    80% confidence
  • Gross adjusted EBITDA margin for Q4 2025 was approximately 83%, above the 75% target

    80% confidence
  • MVCs provide a floor at 95% coverage in 2026, translating to 90% in 2027, protecting revenues if production were lower

    80% confidence
  • Company expects to naturally delever below 3x leverage in the next few years

    80% confidence
  • Longer lateral wells not only improve economics and breakevens but produce same volume with fewer wells, reducing well connect capital requirements

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com
Hess Midstream (HESM) Q4 2025 Earnings Transcript — Source | Via News | Finance Via News